HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

Résumé : To compare the efficacy and safety of subcutaneous (SC) and intravenous (IV) abatacept.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-brest.fr/hal-01557664
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Thursday, July 6, 2017 - 2:11:17 PM
Last modification on : Thursday, May 19, 2022 - 11:48:01 AM

Identifiers

  • HAL Id : hal-01557664, version 1
  • PUBMED : 21618201

Collections

Citation

C. Genovese, A. Covarrubias, G Leon, E Mysler, M Keiserman, et al.. Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.. Arthritis and Rheumatism, Wiley, 2011, 63 (10), pp.2854-64. ⟨hal-01557664⟩

Share

Metrics

Record views

21